Expand CVKD Menu
CVKD MENU

CVKD Latest Press Releases

-- June 18, 2026 --

Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease Globe Newswire 9:00 AM

-- June 15, 2026 --

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026 Globe Newswire 8:30 AM

-- June 3, 2026 --

Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event Globe Newswire 9:00 AM

-- May 19, 2026 --

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 Globe Newswire 4:30 PM

-- May 7, 2026 --

Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA Globe Newswire 8:30 AM

-- April 30, 2026 --

Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT) Globe Newswire 8:30 AM

-- March 31, 2026 --

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting Globe Newswire 8:45 AM

-- March 13, 2026 --

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing Globe Newswire 8:35 AM

-- March 12, 2026 --

Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes Globe Newswire 8:00 AM

-- March 10, 2026 --

Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th Globe Newswire 10:21 AM

-- March 2, 2026 --

Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion Globe Newswire 8:00 AM

-- February 24, 2026 --

Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes